Keywords: merck, co, isentress, launched, uk, drug, major

Merck & Co's Isentress launched in UK

Article | 28 January 2008

Print This

US drug major Merck & Co's HIV integrase inhibitor Isentress (raltegravir) has been launched in the UK. Available as 400mg tablets, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in